Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Acta Médica del Centro
versión On-line ISSN 2709-7927
Resumen
MADRIGAL MORA, Liovesky; YANES MILIAN, Belkis y HERNANDEZ FIGUEIRAS, Miladys Eladia. Therapy with biomodulin T in vulnerable patients to COVID-19. Acta méd centro [online]. 2021, vol.15, n.4, pp. 488-496. Epub 31-Dic-2021. ISSN 2709-7927.
Introduction:
the biomodulin T has cyto-restorative and immunomodulatory action by stimulating lymphoblastoid mitosis, in that way the differentiation of T-lymphocytes is normalized; in models of acute inflammation, edema and chronic inflammation showed an anti-inflammatory effect by modulating the induced inflammatory response.
Objective:
to evaluate the therapeutic response of biomodulin T in susceptible patients to SARS-CoV-2.
Methods:
a descriptive, prospective longitudinal study was carried out at the Immunology Clinic from “Arnaldo Milián Castro” Hospital, in Villa Clara Province, from March 2020 to September 2020. A total of 52 patients who presented personal pathological antecedents that made them susceptible to suffer from SARS CoV-2 virus infection were studied.
Results:
descriptive statistical methods such as frequency tables for the variables age, sex, personal pathological history and response to treatment with biomodulin T were applied. The age group with the most comorbidities was 40 to 59 years, male sex predominated and most patients had a history of chronic obstructive pulmonary disease, diabetes mellitus and arterial hypertension. The largest number of patients had a diagnosis of autoimmune diseases.
Conclusions:
the therapeutic response was satisfactory for all age groups.
Palabras clave : Biomodulin T; COVID-19; personal pathological history.